Not finding it? Sign in to also search OpenAlex live.
-
The Unfolded Protein Response Mediates Resistance in AML and Its Therapeutic Targeting Enhances TKI Induced Cell Death in FLT3-ITD + AML2021 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Endoplasmic Reticulum Stress and Disease
Timo Jaquet, Christian Preisinger, Marlena Bütow, Stefan Tillmann, Nicolas Chatain, Michael Huber, +7 more
2citations -
Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS‐like tyrosine kinase 3 ( FLT3 )‐mutated acute myeloid leukaemia patients: A multicentre real‐world study
Desireé Kunadt, Sven Zukunft, Christoph Röllig, S K Metzelder, Andreas Burchert, Eva Wagner‐Drouet, +50 more
0citations -
STAT5-Activating Oncogenes Drive Oncostatin M Production Causing T Cell Exhaustion and Suppressive Myeloid Cell Recruitment2024 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Michael P. Rassner, Tony Andreas Müller, Kirstyn Anne Crossley, Geoffroy Andrieux, Lena Jakob, Alina Müller-Rudorf, +13 more
1citations -
Remission and Survival after Single Versus Double Induction with 7+3 for Newly Diagnosed Acute Myeloid Leukemia: Results from the Planned Interim Analysis of Randomized Controlled SAL-Daunodouble Trial
Christoph Röllig, Björn Steffen, Nael Alakel, Regina Herbst, Richard Noppeney, Maher Hanoun, +32 more
5citations -
Oncostatin M induced by STAT5-activating oncogenes promotes disease progression in hematologic malignancies2025 Signal Transduction and Targeted Therapy article Medicine Cytokine Signaling Pathways and Interactions Open access
Michael P. Rassner, Tony Andreas Müller, Kirstyn Anne Crossley, Geoffroy Andrieux, Sabina Schaberg, Cornelia Endres, +19 more
1citations -
Venetoclax-Azacitidine As Salvage Therapy and Bridge to Allogeneic Cell Transplantation in Relapsed/Refractory AML Compared to Historical Data of the SAL Registry Study
Julia Marie Unglaub, Richard F. Schlenk, Maher Hanoun, Hans Christian Reinhardt, Jan Moritz Middeke, Kerstin Schäfer‐Eckart, +30 more
4citations -
Randomized Phase II Study of All-Trans Retinoic Acid and Valproic Acid Added to Decitabine in Newly Diagnosed Elderly AML Patients (DECIDER trial): Predictive Impact of TP53 Status
Heiko Becker, Claudia Schmoor, Olga Grishina, Dietmar Pfeifer, Dennis Zimmer, Martina Margrit Crysandt, +27 more
3citations
21 results